Skip to content

Clinical trials

Phase 3 Gastroenteritis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastroenteritis Phase: Phase 3 Country / region: United States Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20092
20101
20111
20141
20161
20181
20201
20212
20223

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bausch Health Americas, Inc.3
Ellodi Pharmaceuticals, LP3
Celgene2
AstraZeneca1
Merck Sharp & Dohme LLC1
Prometheus Laboratories1
RedHill Biopharma Limited1
Shire1
The Cleveland Clinic1
University of Utah1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastroenteritis15
Gastrointestinal Diseases10
Digestive System Diseases7
Hypersensitivity6
Colitis, Ulcerative5
Eosinophilia5
Eosinophilic Esophagitis5
Esophageal Diseases5
Esophagitis5
Intestinal Diseases5

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.